This section contains a selection of Dr. Breggin’s scientific articles spanning 1964 to the present.
Ethical Human Psychology and Psychiatry, Volume 12, Number 2, 2010. Peter R. Breggin, MD The newer antidepressants frequently cause suicide, violence, and manic-like symptoms of activation or overstimulation, presenting serious hazards to active-duty soldiers who carry weapons under stressful conditions. These antidepressant-induced symptoms of activation can mimic posttraumatic stress disorder […]
“Exposure to SSRI Antidepressants In Utero Causes Birth Defects, Neonatal Withdrawal Symptoms, and Brain Damage.” Ethical Human Psychology and Psychiatry, 10, 5-9, 2008. Exposure to SSRIs In Utero Causes Birth Defects.pdf
“Practicle Applications: 22 Guidelines for Counseling and Psychotherapy.” Ethical Human Psychology and Psychiatry, 10, 43-57, 2008. 22Guidelines.pdf
“ECT Damages the Brain: Disturbing News for Patients and Shock Doctors Alike.” Ethical Human Psychology and Psychiatry, 9, 83-86, 2007. ect damages the brain.pdf
“Intoxication Anosognosia: The Spellbinding Effect of Psychiatric Drugs,” International Journal of Risk & Safety in Medicine, 19, 3-15, 2007. ABSTRACT: Why do so many individuals persist in taking psychoactive substances, including psychiatric drugs, after adverse mental and behavioral effects have become severe and even disabling? The author has previously proposed the […]
“Drug Company Suppressed Data on Paroxetine-Induced Stimulation: Implications for Violence and Suicide”, Ethical Human Psychology and Psychiatry, 8, 255-263, 2006. Peter Breggins Paxil Special Report III.pdf
“How GlaxoSmithKline Suppressed Data on Paxil-Induced Akathisia: Implications for Suicidality and Violence”, Ethical Human Psychology and Psychiatry, 8, 91-100, 2006. Peter Breggins Paxil special report II.pdf
“Court Filing Makes Public My Previously Suppressed Analysis of Paxil’s Effects.” Ethical Human Psychology and Psychiatry, 8, 77-84, 2006. courtfiling.pbreggin.2006.pdf
“Politics, Practice, and Breaking News.” Ethical Human Psychology and Psychiatry, 8, 3-6, 2006. politicspractice.pbreggin.2006.pdf
“Recent regulatory changes in antidepressant labels: Implications for activation (stimulation) in clinical practice.” Primary Psychiatry, 13, 57-60, 2006. recentregulatory.pbreggin.2006.pdf
